Reata Pharmaceuticals Announces Phase 3 Study of ADPKD Treatment

According to an article from PM360, Reata Pharmaceuticals has announced that its end-of-Phase 2 meeting with the Food and Drug Administration went according to plan. The American pharmaceutical company based…

Continue Reading Reata Pharmaceuticals Announces Phase 3 Study of ADPKD Treatment
First Patient Enrollment Announced for Angelman Syndrome Nutritional Study
JerzyGorecki / Pixabay

First Patient Enrollment Announced for Angelman Syndrome Nutritional Study

According to a story from BioPortfolio, the keto-medical nutrition company Disruptive Nutrition recently announced that the first patient had been enrolled in a research study which will test a unique…

Continue Reading First Patient Enrollment Announced for Angelman Syndrome Nutritional Study
Finding New Treatment Combinations for Chronic Lymphocytic Leukemia
frolicsomepl / Pixabay

Finding New Treatment Combinations for Chronic Lymphocytic Leukemia

According to a story from Onclive, combination therapies are likely to play an increasing role in the treatment of chronic lymphocytic leukemia. In this video, leukemia treatment experts discuss the…

Continue Reading Finding New Treatment Combinations for Chronic Lymphocytic Leukemia
Close Menu